The First Trust Mid Cap Core AlphaDEX Fund ETF (FNX) exhibits an implied analyst target price of $138.87, suggesting an 11.05% potential upside from its recent trading price of $125.05, based on the weighted average of its underlying holdings' 12-month forward targets. This projected upside is notably influenced by significant analyst optimism for key holdings such as Corcept Therapeutics Inc (CORT) with a 61.32% upside, SM Energy Co. (SM) with 44.95%, and Badger Meter Inc (BMI) with 37.97% upside.
The First Trust Mid Cap Core AlphaDEX Fund ETF (FNX) exhibits an implied 11.05% upside based on a weighted average of analyst 12-month forward targets, suggesting a potential move to $138.87 from its recent price of $125.05. This projection is significantly influenced by strong positive sentiment for a few key underlying holdings. Specifically, analysts see substantial appreciation in Corcept Therapeutics (CORT) with a 61.32% upside to a $135.25 target, SM Energy (SM) with a 44.95% upside to a $39.62 target, and Badger Meter (BMI) with a 37.97% upside to a $237.75 target. Despite the moderately positive overall sentiment, the analysis carries a cautious tone, explicitly questioning whether these high targets are justified or are lagging indicators susceptible to future downgrades. The significant gap between current trading prices and analyst targets highlights potential opportunity but also elevates the risk that market expectations are not aligned with analyst optimism, necessitating further due diligence from investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
